TABLET FOR MULTIPLE ORAL APPLICATIONS
    3.
    发明公开
    TABLET FOR MULTIPLE ORAL APPLICATIONS 审中-公开
    用于多个口腔应用的平板电脑

    公开(公告)号:EP3248594A1

    公开(公告)日:2017-11-29

    申请号:EP16171316.9

    申请日:2016-05-25

    申请人: ratiopharm GmbH

    IPC分类号: A61K9/20 A61K9/46 A61K9/16

    摘要: The present invention relates to a multi-application tablet, in particular to a tablet being designated as a dispersible tablet, oral dispersible tablet, peroral tablet and/or chewable table. Further, the invention relates to a multi-application tablet, wherein the tablet comprises a granulated inner excipient phase and an outer phase comprising the active pharmaceutical ingredient.

    摘要翻译: 本发明涉及一种多用途片剂,特别涉及一种称为分散片剂,口服分散片剂,口服片剂和/或咀嚼片剂的片剂。 此外,本发明涉及多用片剂,其中片剂包含粒状内赋形剂相和包含活性药物成分的外相。

    VERFAHREN ZUR HERSTELLUNG EINER NATRIUM-ION-FREIEN BRAUSETABLETTE ODER EINES SOLCHEN BRAUSEPULVERS ODER -GRANULATS MIT HOHEM X-ION-GEHALT, WOBEI X VERSCHIEDENE STOFFE SEIN KÖNNEN
    4.
    发明公开
    VERFAHREN ZUR HERSTELLUNG EINER NATRIUM-ION-FREIEN BRAUSETABLETTE ODER EINES SOLCHEN BRAUSEPULVERS ODER -GRANULATS MIT HOHEM X-ION-GEHALT, WOBEI X VERSCHIEDENE STOFFE SEIN KÖNNEN 审中-公开
    VERFAHREN ZUR HERSTELLUNG EINER NATRIUM-ION-FREIEN BRAUSETABLETTE ODER EINES SOLCHEN BRAUSEPULVERS ODER -GRANULATS MIT HOHEM X-ION-GEHALT,WOBEI X VERSCHIEDENE STOFFE SEINKÖNNEN

    公开(公告)号:EP3217809A1

    公开(公告)日:2017-09-20

    申请号:EP15820259.8

    申请日:2015-11-12

    IPC分类号: A23L2/40 A23L33/16 A61K9/46

    摘要: Disclosed is a method for producing sodium ion-free X carbonate or hydrocarbonate effervescent powder, granulate or tablets. In said method, the active substances X, where X represents at least calcium carbonate, are humidified with a small amount of alcohol and water and are mixed as a powder with a small amount of lactobionic acid in a partial vacuum obtained by continuous pumping in a vacuum tank. This causes the calcium salt (CaCO
    3 ) of the calcium in the surface layer of the powder particles to react with the lactobionic acid, effervesce and release some CO
    2 . As a result, the pressure in the vacuum tank rises, and once the effervescence reaction has been completed, the internal pressure in the vacuum tank drops to the initial value under the effect of the continuous pumping action, and the powder dries. Upon removal of the dry powder from the vacuum tank, an acid, preferably citric acid, is added as an effervescent agent, and the powder is then optionally pressed to obtain tablets. The obtained sodium ion-free calcium carbonate effervescent tablet thus contains at least calcium carbonate and citric acid as an effervescent agent, the surface layer of the pressed particles having been subjected to preliminary effervescing using lactobionic acid.

    摘要翻译: 公开了生产无钠离子X碳酸盐或碳酸氢盐泡腾粉末,颗粒或片剂的方法。 在所述方法中,其中X代表至少碳酸钙的活性物质X用少量乙醇和水润湿,并且在少量乳糖酸中通过连续泵入 真空罐。 这导致粉末颗粒表层中的钙的钙盐(CaCO 3)与乳糖酸起反应,泡腾并释放一些CO 2。 结果,真空罐内的压力升高,一旦泡腾反应完成,在连续泵送作用的作用下,真空罐中的内部压力降至初始值,并且粉末干燥。 在从真空槽中除去干燥粉末时,加入酸,优选柠檬酸作为泡腾剂,然后任选压制粉末以获得片剂。 因此,所获得的不含钠离子的碳酸钙泡腾片至少包含碳酸钙和柠檬酸作为泡腾剂,压缩颗粒的表面层已经使用乳糖酸进行初步起泡。

    METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION
    9.
    发明公开
    METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION 审中-公开
    制备药物组合物的方法

    公开(公告)号:EP3174522A1

    公开(公告)日:2017-06-07

    申请号:EP15747716.7

    申请日:2015-07-28

    IPC分类号: A61K9/00 A61M11/00 A61M15/00

    摘要: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.

    摘要翻译: 本公开提供了制备药物组合物的方法。 该方法包括将预定量的赋形剂混合物从第二容器转移至第一容器。 从第二容器转移的赋形剂混合物包括液态第二量的氢氟烷烃抛射剂和包含低分子量聚(环氧乙烷)聚合物的第一增溶赋形剂。 该方法还包括在促进形成包含推进剂,聚合物和化合物的混合物的条件下使至少一种药学活性化合物与赋形剂混合物接触。 在转移赋形剂混合物之前,第一容器含有汽相第一量的氢氟烷烃推进剂和有效量的至少一种药学活性化合物。